|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Epidemiology and Cancer Control |
Division of Epidemiology and Biostatistics, University of Illinois at Chicago, 1603 West Taylor Street, MC 923, Chicago, IL 60612 (B.J.M.); 244 East Ogden Avenue, Suite 116, Hinsdale, IL 60521 (C.K., CBTRUS); USA
2 Address correspondence to Carol Kruchko, Central Brain Tumor Registry of the United States, 244 East Ogden Avenue, Suite 116, Hinsdale, IL 60521, USA (cbtrus{at}aol.com).
Abstract
The passage of Public Law 107-260, the Benign Brain Tumor Cancer Registries Amendment Act, in October 2002 has made the collection of all primary brain tumors a reality. However, at the first Consensus Conference on Brain Tumor Definition for Registration in 2002, and during the development of training materials for benign brain tumor collection, several issues were identified that were tabled for future discussion. These and other issues were addressed at the subsequent 2003 Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors, at which the Central Brain Tumor Registry of the United States facilitated a discussion among epidemiologists, neurosurgeons, and neuropathologists. Multidisciplinary consensus was reached on four points, for which the following recommendations were made: (1) amend the histology coding scheme for cysts and tumor-like lesions that currently have a code in the third edition of the International Classification of Disease for Oncology (ICDO), (2) collect data on all instances of specific cysts and tumor-like lesions that are located in brain and other CNS sites but currently lack ICDO codes, (3) establish a new ICDO topography site for skull base tumors for the brain and CNS, and (4) collect data on genetic syndromes in patients diagnosed with brain or CNS tumors. We view this conference as part of a continuing process. Because classification of primary intracranial and other CNS tumors is dynamic, and the registration and coding of these tumors will need to be periodically reviewed.
References
Bigner, S.H., Batra, S.K., and Rasheed, B.K.A. (1998) Mechanisms of altered growth control: Cytogenetics, oncogenes and suppressor genes. In: Bigner, D.D., McLendon, R.E., and Bruner, J.M. (Eds.), Russell and Rubinstein's Pathology of Tumors of the Nervous System, Vol. 1, 6th ed. New York: Oxford University Press, pp. 47-82.
Brain Tumor Progress Review Group (2000) Report of the Brain Tumor Progress Review Group. National Cancer Institute and National Institute of Neurological Disorders and Stroke. Available at prg.nci.nih.gov/brain/finalreport.html (accessed April 15, 2004).
BTWG. Brain Tumor Working Group (1998) Surveillance of Primary Intracranial and Central Nervous System Tumors: Recommendations from the Brain Tumor Working Group. National Coordinating Council for Cancer Surveillance. Available at www.naaccr.org/filesystem/pdf/k-3btwg.pdf. Accessed April 10, 2004.
Fritz, A.G., Percy, C., Jack, A., Shanmugaratnam, K., Sobin, L., Parkin, D.M., and Whelan, S. (Eds.) (2000)International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization.
Greene, F.L. (1997) Strategic alliances, National Coordinating Council for Cancer Surveillance (NCCCS). Paper presented at the Commission on Cancer's Second Annual Meeting, November 14-15, Chicago, Ill.
Kleihues, P., and Cavenee, W.K. (Eds.) (1997) Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency for Research on Cancer, pp. 171-193.
Lindor, N.M., and Greene, M.H. (1998) The concise
handbook of family cancer syndromes. Mayo Familial Cancer Program.
J. Natl. Cancer Inst.
90,1039
-1071.
McCarthy, B.J., Surawicz, T., Bruner, J.M., Kruchko, C., and Davis, F. (2002) Consensus Conference on Brain Tumor Definition for Registration. Neuro-Oncol. 4, 134-145.[Abstract]
McLendon, R.E., and Tien, R.D. (1998) Genetic syndromes associated with tumors and/or hamartomas. In: Bigner, D.D., McLendon, R.E., and Bruner, J.M. (Eds.), Russell and Rubinstein's Pathology of Tumors of the Nervous System, Vol.2 , 6th ed. New York: Oxford University Press,371 -417.
NAACCR. North American Association of Central Cancer Registries (2003) 2004 Implementation Guidelines: Collaborative Staging and Benign/Borderline Intracranial and CNS Tumors. North American Association of Central Cancer Registries. Available at www.naaccr.org/filesystem/pdf/2004 Implementation Guidelines 1103 Errata 0204.pdf. Accessed April 14, 2004.
Public Law 107-260 (2002) Benign Brain Tumor Cancer Registries Amendment Act, 107th Congr. Congr. Rec. 148 (29 October). Available at frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_cong_public_laws&docid=f:publ260.107. Accessed April 14, 2004.
Taylor, M.D., Thapar, K., and Rutka, J.T. (2001) Neurogenetics and the molecular biology of human brain tumors. In: Kaye, A.H., and Laws, E.R., Jr. (Eds.), Brain Tumors: An Encyclopedic Approach, 2nd ed. New York: Churchill Livingstone, pp.71 -103.
Thapar, K., Fukuyama, K., and Rutka, J.T. (1995) Neurogenetics and the molecular biology of human brain tumors. In: Kaye, A.H., and Laws, E.R., Jr. (Eds.), Brain Tumors: An Encyclopedic Approach. New York: Churchill Livingstone, p.69 .
This article has been cited by other articles:
|
|
 |
|
  D. B. Hoelzinger, T. Demuth, and M. E. Berens Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment J Natl Cancer Inst, November 7, 2007; 99(21): 1583 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lim, A. F. Subar, T. Mouw, P. Hartge, L. M. Morton, R. Stolzenberg-Solomon, D. Campbell, A. R. Hollenbeck, and A. Schatzkin Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1654 - 1659. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
